Advertisement

Topics

Interview: CellCentric Prostate Cancer Drug Promises Much

09:05 EDT 15 May 2018 | SCRIP

The Cambridge-based company's CEO Will West tells Scrip that CCS1477 has shown a lot of potential for patients with late-stage...

      

Related Stories

 

Original Article: Interview: CellCentric Prostate Cancer Drug Promises Much

NEXT ARTICLE

More From BioPortfolio on "Interview: CellCentric Prostate Cancer Drug Promises Much"

Advertisement
Quick Search
Advertisement
Advertisement